Physiological roles for ecto-5’-nucleotidase (CD73)
暂无分享,去创建一个
S. Colgan | T. Eckle | L. Thompson | H. Eltzschig | Tobias Eckle | Holger K. Eltzschig | Sean P. Colgan | Linda F. Thompson
[1] C. Clish,et al. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues. , 1998, The Journal of clinical investigation.
[2] S. Jalkanen,et al. IFN-α Induced Adenosine Production on the Endothelium: A Mechanism Mediated by CD73 (Ecto-5′-Nucleotidase) Up-Regulation1 , 2004, The Journal of Immunology.
[3] S. Colgan,et al. Crucial Role for Ecto-5′-Nucleotidase (CD73) in Vascular Leakage during Hypoxia , 2004, The Journal of experimental medicine.
[4] D. Peet,et al. Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch , 2002, Science.
[5] S. Colgan,et al. Dynamic purine signaling and metabolism during neutrophil–endothelial interactions , 2005, Purinergic Signalling.
[6] R. Olson,et al. Release of ATP during host cell killing by enteropathogenic E. coli and its role as a secretory mediator. , 2002, American journal of physiology. Gastrointestinal and liver physiology.
[7] A. Marcus,et al. Thromboregulation by endothelial cells: significance for occlusive vascular diseases. , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[8] B. Mitchell,et al. The 5'-nucleotidases as regulators of nucleotide and drug metabolism. , 2005, Pharmacology & therapeutics.
[9] H. Makita,et al. Plasma concentration of adenosine during normoxia and moderate hypoxia in humans. , 1999, American journal of respiratory and critical care medicine.
[10] S. B. Kramer,et al. Adenosine: a physiological modulator of superoxide anion generation by human neutrophils , 1983, The Journal of experimental medicine.
[11] F. Villarreal,et al. Functional effects of enhancing or silencing adenosine A2b receptors in cardiac fibroblasts. , 2004, American journal of physiology. Heart and circulatory physiology.
[12] S. Jalkanen,et al. Adherent Leukocytes Prevent Adenosine Formation and Impair Endothelial Barrier Function by Ecto-5′-nucleotidase/CD73-dependent Mechanism* , 2003, Journal of Biological Chemistry.
[13] S. Colgan,et al. Epithelial exposure to hypoxia modulates neutrophil transepithelial migration , 1996, The Journal of experimental medicine.
[14] S. Colgan,et al. Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. , 2002, The Journal of clinical investigation.
[15] E. Dejana,et al. Interendothelial Junctions and their Role in the Control of Angiogenesis, Vascular Permeability and Leukocyte Transmigration , 2001, Thrombosis and Haemostasis.
[16] S. Aird. Ophidian envenomation strategies and the role of purines. , 2002, Toxicon : official journal of the International Society on Toxinology.
[17] G. Schuler,et al. Human monocyte derived dendritic cells express functional P2X and P2Y receptors as well as ecto‐nucleotidases , 1999, FEBS letters.
[18] G. Semenza,et al. HIF-1, O2, and the 3 PHDs How Animal Cells Signal Hypoxia to the Nucleus , 2001, Cell.
[19] E. Moore,et al. Acute Hypoxemia in Humans Enhances the Neutrophil Inflammatory Response , 2002, Shock.
[20] P. Olinga,et al. Cytomegalovirus infection increases the expression and activity of ecto‐ATPase (CD39) and ecto‐5′nucleotidase (CD73) on endothelial cells , 2001, FEBS letters.
[21] R. Mrsny,et al. 5'-adenosine monophosphate is the neutrophil-derived paracrine factor that elicits chloride secretion from T84 intestinal epithelial cell monolayers. , 1993, The Journal of clinical investigation.
[22] S. Colgan,et al. Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. , 2004, Blood.
[23] B. Levi,et al. Role of vasodilator‐stimulated phosphoprotein in protein kinase A‐induced changes in endothelial junctional permeability , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[24] M. Montalto,et al. Neutrophil-derived Glutamate Regulates Vascular Endothelial Barrier Function* , 2002, The Journal of Biological Chemistry.
[25] Beverly H. Koller,et al. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice , 1999, Nature Medicine.
[26] F. Luscinskas,et al. The role of endothelial cell lateral junctions during leukocyte trafficking , 2002, Immunological reviews.
[27] Csaba Szabó,et al. Immunomodulatory and neuroprotective effects of inosine. , 2004, Trends in pharmacological sciences.
[28] K. Ley. Plugging the leaks , 2001, Nature Medicine.
[29] W. Flameng,et al. Adenosine, adenosine receptors and myocardial protection: an updated overview. , 2001, Cardiovascular research.
[30] M. Hori,et al. Adenosine and cardioprotection in the diseased heart. , 1999, Japanese circulation journal.
[31] R. Jonge,et al. Cardioprotection by Ischemic Preconditioning , 1998 .
[32] D. Candinas,et al. Apyrase administration prolongs discordant xenograft survival. , 1996, Transplantation.
[33] Silvia Fischer,et al. Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. , 2002, Brain : a journal of neurology.
[34] J. Headrick,et al. Acute adenosinergic cardioprotection in ischemic-reperfused hearts. , 2003, American journal of physiology. Heart and circulatory physiology.
[35] H. Jin,et al. 5′-Nucleotidase Inhibitors and the Myocardial Reactive Hyperemia and Adenosine Content , 1987 .
[36] H. Ballard,et al. The effect of systemic hypoxia on interstitial and blood adenosine, AMP, ADP and ATP in dog skeletal muscle , 2001, The Journal of physiology.
[37] M. Montminy,et al. Transcriptional regulation by cyclic AMP. , 1997, Annual review of biochemistry.
[38] B. Cronstein,et al. Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A(2A) receptor agonists and endotoxin. , 2002, The American journal of pathology.
[39] S. Aird. Taxonomic distribution and quantitative analysis of free purine and pyrimidine nucleosides in snake venoms. , 2005, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.
[40] Patricia D. Christie,et al. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation , 1999, Nature Medicine.
[41] G. Burnstock,et al. Effect of shear stress on the release of soluble ecto‐enzymes ATPase and 5′‐nucleotidase along with endogenous ATP from vascular endothelial cells , 2000, British journal of pharmacology.
[42] G. Burnstock. Purinergic Signaling and Vascular Cell Proliferation and Death , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[43] L. Poellinger,et al. Mechanism of regulation of the hypoxia‐inducible factor‐1α by the von Hippel‐Lindau tumor suppressor protein , 2000, The EMBO journal.
[44] K. Proctor,et al. Potentiation of leukotriene B4-mediated inflammatory response by the adenosine antagonist, 8-phenyl theophylline. , 1991, International journal of microcirculation, clinical and experimental.
[45] D. McDonald,et al. Endothelial Gaps as Sites for Plasma Leakage in Inflammation , 1999, Microcirculation.
[46] S. Vogel,et al. An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors. , 2003, The American journal of pathology.
[47] S. Colgan,et al. Inflammatory Hypoxia: Role of Hypoxia-Inducible Factor , 2005, Cell cycle.
[48] G. Semenza,et al. Hypoxia, HIF-1, and the pathophysiology of common human diseases. , 2000, Advances in experimental medicine and biology.
[49] C. Taylor,et al. Neutrophil-derived 5′-Adenosine Monophosphate Promotes Endothelial Barrier Function via CD73-mediated Conversion to Adenosine and Endothelial A2B Receptor Activation , 1998, The Journal of experimental medicine.
[50] K. Ley,et al. Targeted Disruption of cd73/Ecto-5′-Nucleotidase Alters Thromboregulation and Augments Vascular Inflammatory Response , 2004, Circulation research.
[51] L. Airas. CD73 and adhesion of B-cells to follicular dendritic cells. , 1998, Leukemia & lymphoma.
[52] B. Cronstein,et al. Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides. , 1998, The Journal of clinical investigation.
[53] B. Fredholm,et al. Mice lacking the adenosine A1 receptor are anxious and aggressive, but are normal learners with reduced muscle strength and survival rate , 2002, The European journal of neuroscience.
[54] A. Marcus,et al. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. , 1997, The Journal of clinical investigation.
[55] C. Deng,et al. Impairment of tubuloglomerular feedback regulation of GFR in ecto-5'-nucleotidase/CD73-deficient mice. , 2004, The Journal of clinical investigation.
[56] D. Millhorn,et al. Chronic Hypoxia Enhances Adenosine Release in Rat PC12 Cells by Altering Adenosine Metabolism and Membrane Transport , 2000, Journal of neurochemistry.
[57] D. Candinas,et al. Loss of ATP Diphosphohydrolase Activity with Endothelial Cell Activation , 1997, The Journal of experimental medicine.
[58] G. Gamba. Molecular physiology and pathophysiology of electroneutral cation-chloride cotransporters. , 2005, Physiological reviews.
[59] Y. Ho,et al. Cardiac myocytes exposed to anoxia-reoxygenation promote neutrophil transendothelial migration. , 2001, American journal of physiology. Heart and circulatory physiology.
[60] John E Tomaszewski,et al. Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. , 2004, The Journal of clinical investigation.
[61] J. Marshall,et al. The Roles of Nitric Oxide in Dilating Proximal and Terminal Arterioles of Skeletal Muscle during Systemic Hypoxia , 2003, Journal of Vascular Research.
[62] R. Cotran,et al. The role of endothelial cells in inflammation. , 1990, Transplantation.
[63] P. O’Farrell. Conserved responses to oxygen deprivation. , 2001, The Journal of clinical investigation.
[64] H Zimmermann,et al. 5'-Nucleotidase: molecular structure and functional aspects. , 1992, The Biochemical journal.
[65] K. Jacobson,et al. Coordinated Adenine Nucleotide Phosphohydrolysis and Nucleoside Signaling in Posthypoxic Endothelium , 2003, The Journal of experimental medicine.
[66] S. Schiffmann,et al. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor , 1997, Nature.
[67] I. Novak. ATP as a signaling molecule: the exocrine focus. , 2003, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.
[68] M. J. Broekman,et al. Metabolic Control of Excessive Extracellular Nucleotide Accumulation by CD39/Ecto-Nucleotidase-1: Implications for Ischemic Vascular Diseases , 2003, Journal of Pharmacology and Experimental Therapeutics.
[69] M. Hori,et al. Cardioprotection due to preconditioning correlates with increased ecto-5'-nucleotidase activity. , 1996, The American journal of physiology.
[70] F. Di Virgilio,et al. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. , 2001, Blood.
[71] M. Aldrich,et al. The importance of adenosine deaminase for lymphocyte development and function. , 2000, Biochemical and biophysical research communications.
[72] Yuan Zhang,et al. Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain. , 2002, The Journal of clinical investigation.
[73] R. Napieralski,et al. Evidence for Coordinated Induction and Repression of Ecto-5'-Nucleotidase (CD73) and the A2a Adenosine Receptor in a Human B Cell Line , 2003, Biological chemistry.
[74] K. Stenmark,et al. Hypoxia decreases lung neprilysin expression and increases pulmonary vascular leak. , 2001, American journal of physiology. Lung cellular and molecular physiology.
[75] K. Gardiner,et al. Role of adenosine in immunomodulation: Review of the literature , 2004, Critical care medicine.
[76] C. Webb,et al. Isolation and characterization of the promoter of the human 5'-nucleotidase (CD73)-encoding gene. , 1995, Gene.
[77] A. Malik,et al. Mechanisms regulating endothelial cell barrier function. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[78] E. Gnaiger,et al. Bioenergetics at low oxygen: dependence of respiration and phosphorylation on oxygen and adenosine diphosphate supply. , 2001, Respiration physiology.
[79] O. Feron,et al. Innate immunity and angiogenesis. , 2004, Circulation research.
[80] C. Wykoff,et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.
[81] R. Mrsny,et al. Surface expression, polarization, and functional significance of CD73 in human intestinal epithelia. , 1997, The Journal of clinical investigation.
[82] A. Marcus,et al. Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39. , 1998, The Journal of clinical investigation.
[83] G. Semenza. Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.
[84] J. Linden. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. , 2001, Annual review of pharmacology and toxicology.
[85] J. Michel,et al. Surface Expression in Endothelial Cells Role of Membrane Lipids , 2003 .
[86] J. Marshall,et al. Cellular mechanisms by which adenosine induces vasodilatation in rat skeletal muscle: significance for systemic hypoxia , 1999, The Journal of physiology.
[87] S. Bradamante,et al. Cardioprotection by ischemic preconditioning. Role of adenosine and glycogen. , 1998, Advances in experimental medicine and biology.